Metacognitive Training-Silver BeWell in Older Adults
Feasibility, Acceptance and Efficacy of Metacognitive Training-Silver BeWell in Older Adults
Universitätsklinikum Hamburg-Eppendorf
40 participants
Feb 21, 2024
INTERVENTIONAL
Conditions
Summary
The present study seeks to examine the feasibility, acceptance and efficacy of Metacognitive Training-Silver (MCT-Silver) BeWell among older adults (ages 60 years and older) delivered in a community setting (e.g., social-psychiatric community center, nursing homes, etc.).
Eligibility
Inclusion Criteria6
- Informed consent
- Age 60 years or older
- Sufficient command of the German language
- Willingness to participate in intervention over a period of 10 weeks (participants who do not attend the intervention, but complete questionnaires will also be included in the analysis)
- Visual and auditory acuity adequate for participation in group sessions
- Ability to participate in the group setting (ability to participate in the group setting will be assessed during a screening interview (e.g., adequate social skills)).
Exclusion Criteria2
- Acute suicidality as assessed by BDI-II Item 9
- Dementia (MMSE \< 24) or evidence of severe organic brain dysfunction
Interventions
Metacognitive Training- Silver BeWell is a cognitive behavioral based group intervention, which focuses on helping participants gain (metacognitive) distance from thought and behavioral patterns as well as behaviors and ER-strategies that are implicated in the onset of depression and reduced overall mental well-being. In 10 modules, MCT-Silver addresses issues specific to later life such as coping with physical changes and loss, as well as adapting to new (social) roles. The program also includes modules on identifying and re-defining values in later life, acceptance of negative feelings and resilience. In the training participants are made aware of information processing biases that have been shown to contribute to the onset of depression through engaging exercises using examples from daily life. Groups are comprised of up to 10 participants. Each session is 90 minutes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06312241